Changes and Challenges in Medicare: What Beneficiaries Need to Know
Approximately 70 million individuals are currently enrolled in Medicare, a federal health insurance program designed for those aged 65 and older, as well as certain younger individuals with disabilities. Significant changes to the Medicare system are anticipated in 2026, which will impact the budgets of its beneficiaries.
A notable shift this year was the 9.7% increase in Part B premiums, which cover outpatient care. This adjustment marks the largest rise in four years and consumes more than a quarter of the year's 2.8% Social Security cost-of-living adjustment. Additionally, cost pressures have compelled some insurers offering Medicare Advantage plans to scale back or eliminate additional benefits, and in some cases, withdraw from certain markets.
Despite these challenges, there are positive developments for Medicare beneficiaries, such as new drug pricing policies under the Inflation Reduction Act of 2022. Beginning on January 1, these policies allow Medicare to negotiate lower prices for certain medications. Key drugs affected include Eliquis, Xarelto, Jardiance, Januvia, and Entresto, with the Centers for Medicare & Medicaid Services (CMS) projecting a 50% price reduction by 2025 for individuals using these medications.
Furthermore, Congress has extended crucial telehealth provisions until 2027. These provisions expand access to telehealth services by permitting beneficiaries to receive care from home through video or audio, broadening the range of covered services, and including audio-only options for those unable to use video technology.
A pilot program launched this January mandates AI-driven prior authorization for some medical services under original Medicare in six states. The processes employ artificial intelligence to assist with reviewing requests for certain procedures, although final decisions are made by licensed clinicians.
Regarding Medicare Advantage, the Trump administration proposed minimal increases to reimbursement rates for 2026, potentially affecting plan benefits and costs. Although the finalized rates were slightly higher than initially suggested, they may still necessitate adjustments to coverage in future offerings. For Medicare Advantage enrollees, closely examining the "annual notice of change" for cost and benefit adjustments is crucial. The annual open enrollment period presents an opportunity to reassess and modify plans, and a separate Medicare Advantage open enrollment period offers additional flexibility for reevaluation.